Additional evidence about the role of CD8+ T cells in NASH has been generated in animal models either lacking these cells (37, 38) or effector molecules, such as IFNγ (44) or perforin (18). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.